George Yancopoulos

Place

• Now
  25th
• Last week
  27th
• Two weeks ago
  26th
• Three weeks ago
  26th

George Yancopoulos is a prominent billionaire and scientist based in the United States, renowned for his pioneering work in biotechnology and pharmaceuticals. As the co-founder, President, and Chief Scientific Officer of Regeneron Pharmaceuticals, Yancopoulos has been instrumental in leading groundbreaking research and development efforts that have transformed the treatment of various diseases.

Yancopoulos co-founded Regeneron in 1988 with a vision to apply genetic research and technology to develop novel therapies for serious medical conditions. Under his leadership, Regeneron has achieved notable success in developing innovative drugs, particularly in the fields of ophthalmology, oncology, and inflammatory diseases.

One of Yancopoulos' most notable achievements includes the development of EYLEA® (aflibercept), a leading treatment for wet age-related macular degeneration and other eye diseases, which has significantly improved patient outcomes globally.

Beyond EYLEA®, Yancopoulos has overseen the development of other groundbreaking therapies, including treatments for cholesterol management and immune-mediated diseases. His commitment to scientific innovation and rigorous research has positioned Regeneron as a leader in biopharmaceuticals.

Yancopoulos' contributions to science and medicine have earned him numerous accolades, including election to the National Academy of Sciences and recognition as one of the world's most influential people in biopharma. His leadership at Regeneron continues to drive advancements in biotechnology, addressing unmet medical needs and improving healthcare outcomes for patients worldwide.

In addition to his scientific achievements, George Yancopoulos is involved in philanthropy, supporting initiatives that promote education, scientific research, and healthcare access. His dedication to advancing science and improving human health underscores his significant impact on both the biotechnology industry and society as a whole.

Share

Your involvement